Sarepta Therapeutics (SRPT) ROE US GAAP (year values)

FY2021 FY2022 FY2023 FY2024 FY2025   LTM ? CAGR 5 years ?
ROE, % ? -45.1% -182.7% -62.4% 15.4% -62.5%   4.32%  
Changes by years, y/y, % +28pp -138pp +120pp +78pp -78pp     -3.0%

Sarepta Therapeutics. ROE, %

Sarepta Therapeutics. ROE, changes, pp

Sarepta Therapeutics (SRPT) ROE US GAAP (quarter values)

FY2025Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2026Q1   LTM ?
ROE, % ? -21.7% -4.27% -20.6% -62.5% 4.32%   4.32%
Changes by years, y/y, % -23pp -9pp -31pp -78pp +26pp    
Changes by quarters, q/q, % -37pp +17pp -16pp -42pp +67pp    

Sarepta Therapeutics. ROE, %

Sarepta Therapeutics. ROE, changes, pp

Sarepta Therapeutics. ROE, changes, pp